Literature DB >> 28799083

Vaccination coverage and mortality after splenectomy: results from an Italian single-centre study.

Antonio Di Sabatino1,2, Marco Vincenzo Lenti3, Francesco Paolo Tinozzi4, Marina Lanave5, Ivana Aquino6, Catherine Klersy5, Piero Marone7, Carlo Marena5, Andrea Pietrabissa4, Gino Roberto Corazza3.   

Abstract

Splenectomy is a well-recognised risk factor for life-threatening overwhelming post-splenectomy infection (OPSI). To prevent OPSI, immunisations against encapsulated bacteria (S. pneumoniae, N. meningitidis, H. influenzae) and influenza virus are recommended. However, there is still a lack of uniformity and poor compliance with these recommendations. Following a local physicians' awareness campaign regarding the importance of vaccine prophylaxis of splenectomised patients, we aimed to register vaccination coverage, mortality and infection rates in all patients who underwent splenectomy at our hospital, over a six-year time span. Reasons for splenectomy, patients' compliance with vaccinations, mortality and infectious events were recorded. The reasons for splenectomy in the 216 identified patients (mean age 58.2 ± 14; M:F ratio 1.4:1) were haematologic disorders (38.8%), solid tumours (28.7%), traumatic rupture (22.7%) and other causes (9.7%). A total of 146 patients (67.6%) received at least one of the four vaccines. Overall, the mortality rate was significantly greater in unvaccinated compared to vaccinated patients (p < 0.001), although after the adjustment for the cause of splenectomy the statistical significance was lost (p = 0.085) due to the burden of solid tumour-related mortality. Among the 21 reported cases of OPSI, eight were fatal and five were potentially vaccine-preventable. Our results show that two-thirds of splenectomised patients comply with vaccine prophylaxis. Future interventional studies or ad hoc registries might overcome barriers to vaccination or intentional non-compliance.

Entities:  

Keywords:  Meningococcal; Overwhelming post-splenectomy infection; Pneumococcal; Prophylaxis; Splenectomy

Mesh:

Year:  2017        PMID: 28799083     DOI: 10.1007/s11739-017-1730-9

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  39 in total

Review 1.  Review of guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen: prepared on behalf of the British Committee for Standards in Haematology by a working party of the Haemato-Oncology task force.

Authors:  John M Davies; Michael P N Lewis; Jennie Wimperis; Imran Rafi; Shamez Ladhani; Paula H B Bolton-Maggs
Journal:  Br J Haematol       Date:  2011-11       Impact factor: 6.998

Review 2.  A review of guidance on immunization in persons with defective or deficient splenic function.

Authors:  Ernest Kuchar; Katarzyna Miśkiewicz; Monika Karlikowska
Journal:  Br J Haematol       Date:  2015-08-28       Impact factor: 6.998

3.  [Long-term infectious risks after splenectomy: A retrospective cohort study with up to 10 years follow-up].

Authors:  E Meriglier; M Puyade; M Carretier; F Roblot; P Roblot
Journal:  Rev Med Interne       Date:  2017-02-09       Impact factor: 0.728

Review 4.  Infection associated with asplenia: risks, mechanisms, and prevention.

Authors:  B Styrt
Journal:  Am J Med       Date:  1990-05       Impact factor: 4.965

5.  A study of 42 episodes of overwhelming post-splenectomy infection: is current guidance for asplenic individuals being followed?

Authors:  D J Waghorn; R T Mayon-White
Journal:  J Infect       Date:  1997-11       Impact factor: 6.072

6.  Vaccination coverage and awareness of infectious risks in patients with an absent or dysfunctional spleen in the Netherlands.

Authors:  A Meerveld-Eggink; O de Weerdt; G T Rijkers; H van Velzen-Blad; D H Biesma
Journal:  Vaccine       Date:  2008-10-09       Impact factor: 3.641

7.  Bordetella holmesii bacteremia: a newly recognized clinical entity among asplenic patients.

Authors:  Colin W Shepard; Maryam I Daneshvar; Robyn M Kaiser; David A Ashford; David Lonsway; Jean B Patel; Roger E Morey; Jean G Jordan; Robbin S Weyant; Marc Fischer
Journal:  Clin Infect Dis       Date:  2004-03-01       Impact factor: 9.079

8.  Effects of a pharmacy-driven perisplenectomy vaccination program on vaccination rates and adherence to guidelines.

Authors:  Vanessa Meier-Stephenson; Shelly McNeil; Andrea Kew; Jennifer Sweetapple; Kara Thompson; Kathryn Slayter
Journal:  Can J Hosp Pharm       Date:  2014-07

9.  B-1a B cells that link the innate and adaptive immune responses are lacking in the absence of the spleen.

Authors:  Hedda Wardemann; Thomas Boehm; Neil Dear; Rita Carsetti
Journal:  J Exp Med       Date:  2002-03-18       Impact factor: 14.307

Review 10.  Bacterial Infections Following Splenectomy for Malignant and Nonmalignant Hematologic Diseases.

Authors:  Giuseppe Leone; Eligio Pizzigallo
Journal:  Mediterr J Hematol Infect Dis       Date:  2015-10-13       Impact factor: 2.576

View more
  5 in total

1.  Impact of a spleen registry on optimal post-splenectomy vaccination and care.

Authors:  Sarah Luu; Claire Dendle; Penelope Jones; Samar Ojaimi; Ian J Woolley
Journal:  Hum Vaccin Immunother       Date:  2018-08-27       Impact factor: 3.452

2.  Sclerosing angiomatoid nodular transformation of the spleen, a rare cause for splenectomy: Two case reports.

Authors:  Sophia Chikhladze; Ann-Kathrin Lederer; Stefan Fichtner-Feigl; Uwe A Wittel; Martin Werner; Konrad Aumann
Journal:  World J Clin Cases       Date:  2020-01-06       Impact factor: 1.337

3.  [Invasive pneumococcal infection prevention in asplenic patients].

Authors:  J Rodríguez-García; R Fernández-Santos; E Ruiz de Gopegui-Bordes; O Hidalgo-Pardo
Journal:  Rev Esp Quimioter       Date:  2020-01-03       Impact factor: 1.553

Review 4.  Preventing Infections by Encapsulated Bacteria Through Vaccine Prophylaxis in Inflammatory Bowel Disease.

Authors:  Marco Vincenzo Lenti; Caterina Mengoli; Marta Vernero; Nicola Aronico; Laura Conti; Federica Borrelli de Andreis; Sara Cococcia; Antonio Di Sabatino
Journal:  Front Immunol       Date:  2020-03-23       Impact factor: 7.561

5.  401 consecutive minimally invasive distal pancreatectomies: lessons learned from 20 years of experience.

Authors:  Alessandro Esposito; Marco Ramera; Luca Casetti; Matteo De Pastena; Martina Fontana; Isabella Frigerio; Alessandro Giardino; Roberto Girelli; Luca Landoni; Giuseppe Malleo; Giovanni Marchegiani; Salvatore Paiella; Antonio Pea; Paolo Regi; Filippo Scopelliti; Massimiliano Tuveri; Claudio Bassi; Roberto Salvia; Giovanni Butturini
Journal:  Surg Endosc       Date:  2022-01-31       Impact factor: 3.453

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.